Stephen Cunningham

Director/Miembro de la Junta en Engrail Therapeutics, Inc. .

Health Technology

Perfil

Stephen Cunningham is currently the Director & Chief Development Officer at Engrail Therapeutics, Inc. He previously worked as a Director at Chase Pharmaceuticals Corp.

Cargos activos de Stephen Cunningham

Empresas	Cargo	Inicio
Engrail Therapeutics, Inc. Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA.	Director/Miembro de la Junta	-

Todos los cargos activos de Stephen Cunningham

Antiguos cargos conocidos de Stephen Cunningham.

Empresas	Cargo	Fin
Chase Pharmaceuticals Corp. Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC.	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Stephen Cunningham.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Stephen Cunningham.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Chase Pharmaceuticals Corp. Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC.	Health Technology
Engrail Therapeutics, Inc. Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA.	Health Technology